Team Members

Tweets

Sano Point-of-Care Diagnostics

Web: N/A
Class: N/A

Company Description

Low Cost, Point of Care Biomarker Diagnostic Platform Sano offers a disposable, low cost, Point-of-Care (POC) biomarker detection platform with first focus on a chronic wound diagnostic that quantitatively measures wound biochemistry (enzymes called MMPs) to personalize treatment, promote faster healing, and reduce treatment costs. In parallel, Sano will trial and commercialize an early equine arthritis diagnostic for earlier revenue in Q4 2014. Six other human and vet disease modalities that are characterized by spiked MMP concentrations will be evaluated and prioritized sequentially thereafter.

03/14/2014 05:37 PM
clinical trials collaborators, wound care strategic partners, investors

Updates

No Updates Yet!